Development and Validation of a Novel Acute Myeloid Leukemia–Composite Model to Estimate Risks of Mortality

Overview of attention for article published in JAMA Oncology, September 2017

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (95th percentile)
Above-average Attention Score compared to outputs of the same age and source (61st percentile)

Mentioned by

news: 1 news outlet
twitter: 48 X users
patent: 2 patents
facebook: 1 Facebook page

googleplus: 2 Google+ users
guideline: 2 clinical guideline sources
podcasts: 1 podcast

Readers on

mendeley: 136 Mendeley

So far, Altmetric has seen 73 X posts from 48 X users, with an upper bound of 682,256 followers.

Acute Myeloid Leukemia–Composite Model for Mortality Risk Estimates https://t.co/3KxRvSz4Jz Can a model incorporating patient-specific (comorbidities and age) #AML-specific features (cytogenetic and molecular alterations) predict mortality after AML trea…

RT @JAMAOnc: https://t.co/RI9MOAj3nE

https://t.co/RI9MOAj3nE

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 69 additional X posts.